# Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)

> **NCT06191900** · NA · TERMINATED · sponsor: **Grit Biotechnology** · enrollment: 4 (actual)

## Conditions studied

- Adult
- Gynecological Tumors

## Interventions

- **BIOLOGICAL:** Autologous tumor infiltrating lymphocyte injection（GT201）

## Key facts

- **NCT ID:** NCT06191900
- **Lead sponsor:** Grit Biotechnology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-06-05
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** The study was terminated from a business perspective.
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06191900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06191900, "Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06191900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*